Effect of sucralfate granules in suspension on endoscopic variceal sclerotherapy induced ulcer: Analysis of the factors determining ulcer healing

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 2, 1998, Pages 225-231

  Yang, Wen Guh ^a   Hou, Ming Chih ^a,b   Lin, Han Chieh ^a   Kuo, Benjamin Ing Tieu ^a   Lee, Fa Yauh ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Oesophageal ulcers; Sclerotherapy; Sucralfate

Indexed keywords

ALUMINUM HYDROXIDE; ANTACID AGENT; MAGNESIUM HYDROXIDE; SUCRALFATE; TETRADECYL SULFATE SODIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS ULCER; ESOPHAGUS VARICES BLEEDING; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULCER HEALING;

EID: 0031931792     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00642.x     Document Type: Article

References (29)

1. Hashizume M, Kitano S, Koyanagi N et al. Endoscopic injection sclerotherapy for 1000 patients with esophageal varices: A nine-year prospective study. Hepawlogy 1992; 15: 69-75.
2. Infantc-Rivard C, Esnaola S, Villeneuve JP. Role of endoscopic variceal sclerotherapy in long-term management of variceal bleeding. Gastroenterology 1989; 96: 1087-92.
3. MacDougall BRD, Theodoss A, Westaby D, Dawson JL, Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet 1982; 1: 124-7.
4. Schuman BM, Beckman JW, Tedesco FJ, Griffin JW, Assad RT. Complications of endoscopie injection sclerotherapy: A review. Am. J. Gastroenterol. 1987; 82: 823-30.
5. Sarles HE, Sanowski RA, Talbert G. Course and complications of endoscopie variceal sclerotherapy: A prospective study of 50 patients. Am. J. Gastroenterol. 1985; 80: 595-9.
6. Chung R, Lewis JW. Cost of treatment of bleeding esophageal varices. Arch. Surg. 1983; 118: 482-5.
7. Sarin SK, Nanda R, Vij JC, Anand BS. Oesophageal ulceration after sclerotherapy - complication or an accompaniment? Endoscopy 1986; 18: 44-5.
8. Singal A, Sarin SK, Misra SP, Broor SL. Ulceration after esophageal and gastric variceal sclerotherapy - influence of sucralfate and other factors on healing. Endoscopy 1988; 20(5): 238-40.
9. Roark G. Treatment of postsclerotherapy esophageal ulcers with sucralfate. Gastrointest. Endosc. 1984; 30: 9-10.
10. Sorensen TIA, Burcharth F, Pedersen NL, Findhal F. Oesophageal stricture and dysphagia following endoscopic sclerotherapy for bleeding varices. Gut 1984; 25: 473-7.
11. Bacon BR, Camera DS, Duffy MC. Severe ulceration and delayed perforation of the esophagus after endoscopic variceal sclerotherapy. Gastrointest. Endosc. 1987; 33: 311-5.
12. Polson RJ, Westaby D, Gimson AE et al. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology 1989; 10: 279-82.
13. Westaby D, Melia W, MacDougall BRD, Hegarty JE, Williams R. Injection sclerotherapy for oesophageal varices: A prospective randomized trial of different treatment schedules. Gut 1984; 25: 129-32.
14. Westaby D, MeliaW, Hegarty J, Gimson AES, Stellon AJ, William R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 1986; 6: 673-5.
15. Hou MC, Lin HC, Kuo BIT, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial. Hepatology 1995; 21: 1517-22.
16. Elsborg L, Boysen K, Bruusgarrd A, Reinicke V. Sucralfate versus placebo treatment in duodenal and prepyloric ulcer: A clinical endoscopic, double blind, controlled investigation. Hepatogastroenterology 1984; 31: 269-71.
17. Evreux M. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis. Am. J. Med. 1987; 83 (Suppl. 3B): 48-50.
18. McCarthy DM. Drug therapy. Sucralfate. N. Engl. J. Med. 1991; 325: 1017-25.
19. Beppu K, Indokuchi K, Koyanagi N et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest. Endosc. 1981; 27: 213-9.
20. Jensen DM. Sclerosants for injection sclerosis of esophageal varices. Gastrointest. Endosc. 1983; 29: 315-7.
21. Rose JDR, Crane MD, Smith PM. Factors affecting successful endoscopic sclerotherapy for oesophageal varices. Gut 1983; 24: 946
22. Powers BJ, Van Ness MM, Alexander HR, Robinowitz M, Howard BK, Cattau EL. Study of differing outcomes of paravenous versus intravenous sclerotherapy: ulceration versus thrombosis. Gastrointest. Endosc. 1986; 32: 176 (Abs).
23. Korula J, Balart LA, Radvan G et al. A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 1986; 5: 584-9.
24. Kitano S, Yamada H, Hashizume M, Higashi H, Sugimachi K. Trial of sclerosing agents in patients with oesophageal varices. Br. J. Surg. 1988; 75: 751-3.
25. Singal A, Sarin SK, Sood GK, Broor SL. Ulcers after intravariceal sclerotherapy: correlation of symptoms and factors affecting healing. J. Clin. Gastroenterol. 1990; 12: 250-4.
26. Paquet KJ, Koussouris R, Keinath R, Rambach W, Kala JF. A comparison of sucralfate with placebo in the treatment of esophageal ulcers following therapeutic endoscopic slcerotherapy of esophageal varices - a prospective controlled randomized trial. Am. J. Med. 1991; 91 (Suppl. 2A): S147-50.
27. Tabibian N, Smith LJ, Graham DY. Sclerotherapy-associated esophageal ulcers: Lessons from a double-blind, randomized comparison of sucralfate suspension versus placebo. Gastrointest. Endosc. 1989; 35: 312-5.
28. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345-51.
29. Dixon JS, Worthington PR, Mills JG, Wood JR. Geographic differences of gastric ulcer healing rate in patients treated with ranitidine or placebo. Aliment. Pharmacol. Ther. 1989; 3: 353-65.